Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder of the central nervous system (CNS). Reliable biomarkers are urgently needed for its diagnosis and management, and as clues to its pathogenesis, in which EBV is implicated. Objective: To measure IgG antibodies against EBV nuclear antigen-1 (EBNA-1) and innate inflammation status in paired serum and cerebrospinal fluid (CSF) samples from untreated relapsing-remitting MS (RRMS) patients. Materials and methods: Anti-EBNA-1 IgG titers and IL-8, IL-1β, IL-6, IL-10, TNF-α and IL-12p70 cytokine levels were measured in 20 untreated RRMS-patients and 17 healthy controls. Results: We found higher serum anti-EBNA-1 IgG and IL-8 levels in RRMS-patients than in healthy controls. Interestingly, levels of IL-8 -relative to total protein -were much higher in the CSF, whereas the anti-EBNA-1 antibodies were significantly higher in the sera. More detailed analysis showed that anti-EBNA-1 antibodies relative to total IgG were also higher in the serum in the majority of RRMS patients compared to CSF. Levels of anti-EBNA-1 IgG and IL-8 showed a strong correlation between serum and CSF. Conclusion: These findings in newly diagnosed RRMS-patients imply anti-EBNA-1 antibody production mainly in the periphery and innate immune responses preferentially in the CNS. Both their potential as disease biomarkers and their implications for the pathogenesis of MS warrant further investigation.
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Introduction
MS is characterized by inflammatory plaques of demyelination in the MS brain and spinal cord. The drivers of neuroinflammation and neurodegeneration in MS are subjects of intensive research, and so is the identification of potential risk factors and biomarkers (Ramagopalan et al., 2010) .
Late Epstein-Barr virus (EBV) infection is one established risk factor for MS. EBV is a γ-herpesvirus with a population prevalence of N 90% in adults in western countries (Pariente et al., 2007) . It infects predominantly B-lymphocytes and persists in rare memory B-cells in the periphery. A history of overt glandular fever (symptomatic infectious mononucleosis), especially in the late teens or in adulthood, confers a more than twofold higher MS-risk (Thacker et al., 2006) . Conversely, the risk is extremely low in rare individuals who are seronegative for EBV (Levin et al., 2010; Pakpoor et al., 2013) , and increases sharply Journal of Neuroimmunology 306 (2017) [40] [41] [42] [43] [44] [45] 
